Granulocyte-colony stimulating factor improves MDX mouse response to peripheral nerve injury

PLoS ONE

Volumn 7, Issue 8, 2012, Pages

  Simões, Gustavo Ferreira ^a   de Oliveira, Alexandre Leite Rodrigues ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; SYNAPTOPHYSIN;

ALPHA NERVE FIBER; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTOSIS; C57BL 10 MOUSE; CONTROLLED STUDY; DRUG MECHANISM; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MOUSE; NEUROPROTECTION; NONHUMAN; PERIPHERAL NERVE INJURY; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; SPINAL CORD INJURY; STRAIN DIFFERENCE; SYNAPTIC TRANSMISSION; TRANSMISSION ELECTRON MICROSCOPY; X CHROMOSOME LINKED MUSCULAR DYSTROPHIC MOUSE;

ANIMALS; AXOTOMY; BIOLOGICAL MARKERS; CALCIUM-BINDING PROTEINS; GENE EXPRESSION REGULATION; GRANULOCYTE COLONY-STIMULATING FACTOR; HISTOCOMPATIBILITY ANTIGENS; MALE; MICE; MICE, INBRED MDX; MICROFILAMENT PROTEINS; NEUROGLIA; NEURONS; NEUROPROTECTIVE AGENTS; PERIPHERAL NERVE INJURIES; SCIATIC NERVE; SPINAL CORD; SYNAPSES;

EID: 84865051129     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0042803     Document Type: Article

References (75)

1. Bulfield G, Siller WG, Wight PAL, Moore KJ, (1984) X-chromosome linked muscular dystrophy (mdx) in the mouse. Proceedings of the National Academy of Sciences, USA 81: 1189-1192.
2. Tanabe Y, Esaki K, Nomura T (1986) Skeletal muscle pathology in X chromosome-linked muscular dystrophy (mdx) mouse. Acta Neuropathologica 69, 91-95.
3. Torres LF, Duchen LW, (1987) The mutant mdx: inherited myopathy in the mouse. Morphological studies of nerves, muscles and end-plates. Brain. Pt 2: 269-99.
4. Hoffman EP, Brown RH Jr, Kunkel LM, (1987) Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell 51: 919-928.
5. Ryder-Cook AL, Sicinskil P, Thomas K, Davies KE, Worton RG, et al. (1988) Localization of the mdx mutation within the mouse dystrophingene. The EMBO Journal 7(10): 3017-3021.
6. Sicinski P, Geng Y, Ryder-Cook AS, Barnard EA, Darlison MG, et al. (1989) The molecular basis of muscular dystrophy in the mdx mouse: a point mutation. Science 244(4912): 1578-80.
7. Lefaucheur JP, Pastoret C, Sebille A, (1995) Phenotype of dystrophinopathy in old mdx mice. Anat Rec. 242(1): 70-76.
8. Pastoret C, Sebille A, (1995) MDX mice show progressive weakness and muscle deterioration whith age. Journal of Neurological Sciences 129: 97-105.
9. Nonaka I, (1998) Animals models of muscular dystrophies. Loboratory Anim. Sci. 48: 8-16.
10. Lagrota-Candido J, Vasconcellos R, Cavalcanti M, Bozza M, Savino W, et al. (2002) Resolution of skeletal muscle inflammation in mdx dystrophic mouse is accompanied by increased immunoglobulin and interferon-gama production. Int. J. Exp. Path. 83: 121-132.
11. Lidov HG, Byers TJ, Kunkel LM, (1993) The distribuition of dystrphin in the murine central nervous system: an immunocytochemical study. Neuroscience 54: 167-187.
12. Sbriccoli A, Santarelli M, Carreta D, Pinto F, Granato A, et al. (1995) Architectural changes of the cortiço-spinal system in the dystrophin defective mdx mice. Neuroscience Letters 200: 53-56.
13. Carreta D, Santarelli M, Vanni D, Carrai R, Sbriccoli A, et al. (2001) The organization of spinal projecting brainstem neurons in an animal modelo f muscular dystrophy: A retrograde tracinig study on mdx mutante mice. Brain Research 895: 213-222.
14. Daoud F, Candelario-Martinez A, Billard J-M, Avital A, Khelfaoui M, et al. (2009) Role of Mental Retardation-Associated Dystrophin-Gene Product Dp71 in Excitatory Synapse Organization, Synaptic Plasticity and Behavioral Functions. PLoS ONE 4(8): e65.
15. Simões GF, Oliveira ALR, (2010) Alpha motoneurone input changes in dystrophic MDX mice after sciatic nerve transection. Neuropathol Appl Neurobiol., 36 (1): 55-70.
16. Wong BL, Christopher C, (2002) Corticosteroids in Duchenne muscular dystrophy: a reappraisal. J Child Neurol. 17(3): 183-90.
17. Konishi Y, Chui DH, Hirose H, Kunishita T, Tabira T, (1993) Trophic effect of erythropoietin and other hematopoietic factors on central cholinergic neurons in vitro and in vivo. Brain Res. 609(12): 29-35.
18. Schneider A, Wysocki R, Pitzer C, Krüger C, Laage R, et al. (2006) An extended window of opportunity for G-CSF treatment in cerebral ischemia. BMC Biol. 4: 36.
19. Schäbitz WR, Kollmar R, Schwaninger M, Juettler E, Bardutzky J, et al. (2003) Neuroprotective effect of granulocyte colonystimulating factor after focal cerebral ischemia. Stroke. 34(3): 745-51.
20. Meuer K, Pitzer C, Teismann P, Kruger C, Goricke B, et al. (2006) Granulocyte-colony stimulating factor is neuroprotective in a model of Parkinson's disease. J Neurochem. 97(3): 675-686.
21. Solaroglu I, Cahill J, Jadhav V, Zhang JH, (2006) A novel neuroprotectant granulocyte-colony stimulating factor. Stroke 37(4): 1123-8.
22. Henriques A, Pitzer C, Dupuis L, Schneider A, (2010) G-CSF protects motoneurons against axotomyinduced apoptotic death in neonatal mice. MC Neuroscience 11: 25.
23. Lee ST, Chu K, Jung KH, Ko SY, Kim EH, et al. (2005) Granulocyte colony-stimulating factor enhances angiogenesis after focal cerebral ischemia. Brain Res. 1058(1-2): 120-8.
24. Ohki Y, Heissig B, Sato Y, Akiyama H, Zhu Z, et al. (2005) Granulocyte colony-stimulating factor promotes neovascularization by releasing vascular endothelial growth factor from neutrophils. FASEB J. 19(14): 2005-7.
25. Takagi Y, Omura T, Yoshiyama M, Matsumoto R, Enomoto S, et al. (2005) Granulocyte-colony stimulating factor augments neovascularization induced by bone marrow transplantation in rat hindlimb ischemia. J Pharmacol Sci. 99(1): 45-51.
26. Görgen I, Hartung T, Leist M, Niehörster M, Tiegs G, et al. (1992) Granulocyte colony-stimulating factor treatment protects rodents against lipopolysaccharide-induced toxicity via suppression of systemic tumor necrosis factor-alpha. J Immunol. 149(3): 918-24.
27. Squadrito F, Altavilla D, Squadrito G, Campo GM, Ioculano M, et al. (1997) The effects of recombinant human granulocyte-colony stimulating factor on vascular dysfunction and splanchnic ischaemia-reperfusion injury. Br J Pharmacol. 120(2): 333-9.
28. Hartung T, (1998) Anti-inflammatory effects of granulocyte colonystimulating factor. Curr Opin Hematol. 5(3): 221-5.
29. Heard SO, Fink MP, (1999) Counterregulatory control of the acute inflammatory response: granulocyte colony-stimulating factor has anti-inflammatory properties. CritCare Med. 27(5): 1019-21.
30. Pitzer C, Kruger C, Plaas C, Kirsch F, Dittgen T (2008) Granulocyte-colony stimulating factor improves outcome in a mouse model of amyotrophic lateral sclerosis. Brain; 131, 3335-3347.
31. Schneider A, Kuhn HG, Schäbitz WR, (2005) A role for G-CSF (granulocytecolony stimulating factor) in the central nervous system. Cell Cycle 4(12): 1753-7.
32. Jung KH, Chu K, Lee ST, Kang L, Kim SU, et al. (2006) G-CSF protects human cerebral hybrid neurons against in vitro ischemia. Neurosci Lett. 394(3): 168-73.
33. Kawada H, Takizawa S, Takanashi T, Morita Y, Fujita J, et al. (2006) Administration of hematopoietic cytokines in the subacute phase after cerebral infarction is effective for functional recovery facilitating proliferation of intrinsic neural stem/progenitor cells and transition of bone marrow-derived neuronal cells. Circulation 113(5): 701-10.
34. Begley CG, Lopez AF, Nicola NA, Warren DJ, Vadas MA, et al. (1986) Purified colony-stimulating factors enhance the survival of human neutrophils and eosinophils in vitro: a rapid and sensitive microassay for colony-stimulating factors. Blood. 68(1): 162-6.
35. Burgess AW, Metcalf D, (1980) Characterization of a serum factor stimulating the differentiation of myelomonocytic leukemic cells. Int J Cancer. 26(5): 647-54.
36. Dong F, Dale DC, Bonilla MA, Freedman M, Fasth A, et al. (1997) Mutations in the granulocyte colony-stimulating factor receptor gene in patients with severe congenital neutropenia. Leukemia 11(1): 120-5.
37. Ward AC, (2007) The role of the granulocyte colony-stimulating factor receptor (G-CSF-R) in disease. Front Biosci. 1(12): 608-18.
38. Welte K, Platzer E, Lu L, Gabrilove JL, Levi E, et al. (1985) Purification and biochemical characterization of human pluripotent hematopoietic colony-stimulating factor. Proc Natl Acad Sci USA. 82(5): 1526-30.
39. Hu B, Yasui K, (1997) Effects of colony-stimulating factors (CSFs) on neutrophil apoptosis: possible roles at inflammation site. Int J Hematol. 66(2): 179-88.
40. Henriques A, Pitzer C, Dupuis L, Schneider A, (2010) G-CSF protects motoneurons against axotomy induced apoptotic death in neonatal mice. BMC Neuroscience 2010 11: 25.
41. Koda M, Nishio Y, Kamada T, Someya Y, Okawa A, et al. (2007) Granulocyte colony-stimulating factor (G-CSF) mobilizes bone marrow-derived cells into injured spinal cord and promotes functional recovery after compression-induced spinal cord injury in mice. Brain Res. 1149: 223-31.
42. Nishio Y, Koda M, Kamada T, Someya Y, Kadota R, et al. (2007) Granulocyte colony-stimulating factor attenuates neuronal death and promotes functional recovery after spinal cord injury in mice. J Neuropathol Exp Neurol. 66(8): 724-31.
43. Luo J, Zhang HT, Jiang XD, Xue S, Ke YQ, (2009) Combination of bone marrow stromal cell transplantation with mobilization by granulocyte-colony stimulating factor promotes functional recovery after spinal cord transection. Acta Neurochir (Wien) 151(11): 1483-92.
44. Osada T, Watanabe M, Hasuo A, Imai M, Suyama K, et al. (2010) Efficacy of the coadministration of granulocyte colony-stimulating factor and stem cell factor in the activation of intrinsic cells after spinal cord injury in mice. J Neurosurg Spine. 13(4): 516-23.
45. Dittgen T, Pitzer C, Plaas C, Kirsch F, Vogt G, et al. (2012) Granulocyte-Colony Stimulating Factor (G-CSF) improves motor recovery in the rat impactor model for spi nal cord injury. PLoS ONE 7(1): e29880 doi:10.1371/jo urnal.pone. 0029880.
46. Sanli AM, Serbes G, Calişkan M, Kaptanoǧlu E, Sargon MF, et al. (2010) Effect of granulocyte-colony stimulating factor on spinal cord tissue after experimental contusion injury. J Clin Neurosci. (12): 1548-52.
47. Lee JS, Yang CC, Kuo YM, Sze CI, Hsu JY, et al. (2012) Delayed Granulocyte Colony-Stimulating Factor Treatment Promotes Functional Recovery in Rats With Severe Contusive Spinal Cord Injury. Spine (Phila Pa 1976).1 37(1): 10-7.
48. Zavala F, Abad S, Ezine S, Taupin V, Masson A, et al. (2002) G-CSF Therapy of Ongoing Experimental Allergic Encephalomyelitis Via Chemokine- and Cytokine-Based Immune Deviation. J Immunol.15 168(4): 2011-9.
49. Conradi S (1969) Ultrastructure and distribution of neuronal and glial elements on the motoneuron surface in the lumbosacral spinal cord of the adult cat. Acta Physiol. Scand. Suppl.; 332: 5-48.
50. Tanaka M, Kikuchi H, Ishizu T, Minohara M, Osoegawa M, et al. (2006) Intrathecal upregulation of granulocyte colony stimulating factor and its neuroprotective actions on motor neurons in amyotrophic lateral sclerosis. J Neuropathol Exp Neurol. 65(8): 816-25.
51. Oliveira AL, Thams S, Lidman O, Piehl F, Hökfelt T, et al. (2004) A role for MHC class I molecules in synaptic plasticity and regeneration of neurons after axotomy. PNAS. 101(51): 17843-17848.
52. Zanon RG, Oliveira ALR, (2006) MHC I upregulation influences astroglial reaction and synaptic plasticity in the spinal cord after sciatic nerve transaction. Experimental Neurology 200: 521-531.
53. Emirandetti A, Zanon RG, Sabha MJ, Oliveira ALR, (2006) Astrocyte reactivity influences the number of presynaptic terminals apposed to spinal motoneurons after axotomy. Brain Research 1095: 35-42.
54. Sabha M Jr, Emirandetti A, Cullheim S, Oliveira ALR, (2008) MHC I expression and synaptic plasticity ind different mice strains after axotomy. Synapse 62: 137-148.
55. Lindå H, Piehl F, Dagerlind A, Verge VM, Arvidsson U,et al. 1992. Expression of GAP-43 mRNA in the adult mammalian spinal cord under normal conditions and after different types of lesions, with special reference to motoneurons. Exp. Brain Res. 91: 284-295.
56. Aldskogius H, Liu L, Svensson M (1999) Glial responses to synaptic damage and plasticity. J Neurosci Res. 1999; 58(1): 33-41. Review.
57. Emirandetti A, Zanon RG, Sabha M Jr, Oliveira AL, (2006) Astrocyte reactivity influences the number of presynaptic terminals apposed to spinal motoneurons after axotomy. Brain Res. 2006 1095(1): 35-42.
58. Barreto G, White RE, Ouyang Y, Xu L, Giffard RG, (2011) Astrocytes: targets for neuroprotection in stroke. Cent Nerv Syst Agents Med Chem. 11(2): 164-73.
59. Nedergaard M, Dirnagl U, (2005) Role of glial cells in cerebral ischemia. Glia. 2005 (4): 281-6.
60. del Zoppo GJ, (2009) Inflammation and the neurovascular unit in the setting of focal cerebral ischemia. Neuroscience (1583): 972-82.
61. Kaur C, Ling EA, (2008) Blood brain barrier in hypoxic-ischemic conditions Curr Neurovasc. Res. (1): 71-81.
62. Walz W, (2000) Role of astrocytes in the clearance of excess extracellular potassium. Neurochem Int. 36(4-5): 291-300.
63. Barreto GE, Gonzalez J, Torres Y, Morales L (2011) Astrocytic-neuronal crosstalk: implications for neuroprotection from brain injury. Neurosci Res. (2): 107-13. Epub 2011 Jun 14.
64. Ouyang YB, Voloboueva LA, Xu LJ, Giffard RG, (2007) Selective dysfunction of hippocampal CA1 astrocytes contributes to delayed neuronal damage after transient forebrain ischemia. J Neurosci. 27(16): 4253-60.
65. Anderson CM, Swanson RA, (2000) Astrocyte glutamate transport: review of properties, regulation, and physiological functions. Glia 32(1): 1-14.
66. Dringen R, (2000) Metabolism and functions of glutathione in brain. Prog Neurobiol. 62(6): 649-71.
67. Dringen R, Gutterer JM, Hirrlinger J, (2000) Glutathione metabolism in brain metabolic interaction between astrocytes and neurons in the defense against reactive oxygen species. Eur J Biochem. 267(16): 4912-6.
68. Lindenau J, Noack H, Possel H, Asayama K, Wolf G, (2000) Cellular distribution of superoxide dismutases in the rat CNS. Glia. 2000 Jan 1 29(1): 25-34.
69. Sims NR, Nilsson M, Muyderman H, (2004) Mitochondrial glutathione: a modulator of brain cell death. J Bioenerg Biomembr. 2004 Aug 36(4): 329-33.
70. Swanson RA, Ying W, Kauppinen TM, (2004) Astrocyte influences on ischemic neuronal death. Curr Mol Med. 2004 Mar 4(2): 193-205.
71. Ridet JL, Malhotra SK, Privat A, Gage FH, (1997) Reactive astrocytes: cellular and molecular cues to biological function. Trends Neurosci. 20(12): 570-7.
72. Batchelor PE, Porritt MJ, Martinello P, Parish CL, Liberatore GT, et al. (2002) Macrophages and microglia produce local trophic gradients that stimulate axonal sprouting toward but not beyond the wound edge. Mol Cell Neurosci 21: 436-53.
73. Streit WJ, (2005) Microglia and neuroprotection: implications for Alzheimer's disease. Brain Res Brain Res 48: 234-9.
74. Hanisch UK, Kettenmann H, (2007) Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat Neurosci 10: 1387-94.
75. Cullheim S, Thams S, (2007) The microglial networks of the brain and their role in neuronal network plasticity after lesion. Brain Res 55: 89-96.